The Hearty Soul on MSN
Why science says you should add guava leaf extract for blood sugar and heart health
Nutrition researchers have spent decades building a case for a plant that most North Americans overlook entirely. Guava ...
The Eversense 365 is a CGM system for people with diabetes 18 and older, with an implantable sensor that only needs to be changed once a year. The system's removable transmitter uses an adhesive patch ...
Peptides like insulin and the now-ubiquitous GLP-1 drugs have become some of the most influential molecules in modern ...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. The deficits linked to AD are known to result from the ...
A bipartisan group of senators is aiming to relieve high insulin costs for more Americans. A new bill introduced last week ...
If you’ve been struggling with unstable blood sugar, sudden energy crashes, or unexplained weight gain, Gluco6 might ...
Two organic compounds in the cannabis plant may be the key to reversing fatty liver disease, a silent killer that affects at ...
Magnesium helps the body use insulin more effectively, which may improve blood sugar control. Research suggests low magnesium levels are linked to a higher risk of insulin resistance and type 2 ...
FIVE ON YOUR HEALTH TONIGHT, A NEW TREATMENT OPTION FOR ADULTS LIVING WITH TYPE TWO DIABETES. THE FDA JUST APPROVED THE FIRST WEEKLY SHOT OF INSULIN TO CONTROL BLOOD SUGAR LEVELS. THE MEDICATION, A ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Insulin icodec-abae is a 700 U/mL injectable insulin ...
The FDA approval of Awiqli is a ‘huge deal’ for people looking for an alternative to daily shots, experts say. The FDA just approved Awiqli, a once-weekly insulin treatment for type 2 diabetes. Awiqli ...
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results